Compounds > arctigenin
Page last updated: 2024-08-24

arctigenin and Disease Exacerbation

arctigenin has been researched along with Disease Exacerbation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Azeloglu, EU; Chen, Y; Das, B; Deng, Y; He, JC; Lee, K; Li, X; Liu, R; Ma, Y; Muwonge, AN; Wang, T; Wei, C; Wong, NJ; Yang, S; Zhang, W; Zhong, Y1
Huang, H; Liu, H; Shang, P; Tang, Q; Tang, S; Xu, J; Yang, S; Zhang, J; Zheng, X; Zhong, X; Zhou, W1
Janthamala, S; Jusakul, A; Kimawaha, P; Klanrit, P; Kongpetch, S; Loilome, W; Namwat, N; Techasen, A1

Other Studies

3 other study(ies) available for arctigenin and Disease Exacerbation

ArticleYear
Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes.
    Nature communications, 2019, 10-04, Volume: 10, Issue:1

    Topics: Animals; Arctium; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Furans; Humans; Lignans; Male; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Nitric Oxide Synthase Type III; Podocytes; Protein Phosphatase 2; Streptozocin; Treatment Outcome

2019
Arctigenin prevents the progression of osteoarthritis by targeting PI3K/Akt/NF-κB axis: In vitro and in vivo studies.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:7

    Topics: Animals; Cartilage, Articular; Chondrocytes; Dinoprostone; Disease Models, Animal; Disease Progression; Furans; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lignans; Mice; Molecular Docking Simulation; NF-kappa B; Nitric Oxide Synthase Type II; Nitrous Oxide; Osteoarthritis; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Signal Transduction

2020
Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:10

    Topics: Antigens, CD; Antineoplastic Agents, Phytogenic; Apoptosis; Bile Duct Neoplasms; Biomarkers, Tumor; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Disease Progression; Female; Furans; Humans; Lignans; Male; Middle Aged; Prognosis

2021